Galantamine hydrobromide
-
Galantamine hydrobromide
structure -
-
CAS No:
1953-04-4
-
Formula:
C17H21NO3.BrH
-
Chemical Name:
Galantamine hydrobromide
-
Synonyms:
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide (1:1),(4aS,6R,8aS)-;Galanthamine,hydrobromide;6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-,hydrobromide,(4aS,6R,8aS)-;Galantamine hydrobromide;Nivalin;Nivaline;Galanthamine hydrogen bromide;Nivaline (pharmaceutical);(-)-Galanthamine hydrobromide;Reminyl;Jilkon hydrobromide;Lycoremine hydrobromide;(-)-Galantamine hydrobromide;Razadyne;Tamilin
- Categories:
-
CAS No:
Description
Galantamine Hydrobromide is the hydrobromide salt form of galantamine, a tertiary alkaloid obtained synthetically or naturally from the bulbs and flowers of Narcissus and several other genera of the Amaryllidaceae family with anticholinesterase and neurocognitive-enhancing activities. Galantamine competitively and reversibly inhibits acetylcholinesterase, thereby increasing the concentration and enhancing the action of acetylcholine (Ach). In addition, galantamine is a ligand for nicotinic acetylcholine receptors, which may increase the presynaptic release of Ach and activate postsynaptic receptors. This agent may improve neurocognitive function in mild and moderate Alzheimer' s disease and may reduce abstinence-induced cognitive symptoms that promote smoking relapse.|A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.
Characteristics
41.9
2.74630
White to Off-White Powder
255-256 °C @ Solvent: Ethanol, 85%
-95 ° (C=1.4, H2O)
soluble in water or DMSO;Fairly soluble in hot water; freely soluble in alcohol, acetone, chloroform. Less sol in benzene, ether.
−20°C
0mmHg at 25°C
D20 -93.1° (c = 0.1015 in 15 ml H2O)
166.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
6.1
UN 2811 6.1/PG 3
3
25
45-36/37/39-22
DF8075000
T
P264, P270, P280, P301+P310, P302+P352, P321, P330, P332+P313, P362, P405, P501
H301
|Danger|H301 (99.53%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 212 companies from 10 notifications to the ECHA C&L Inventory.
Drug Information
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)|Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)|Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Galantamin
Galantamine hydrobromide Use and Manufacturing
anticholinesterase, analgesic, antiAlzheimer
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:368.3
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:1
Exact Mass:367.07831
Monoisotopic Mass:367.07831
Topological Polar Surface Area:41.9
Heavy Atom Count:22
Complexity:440
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a cholinesterase inhibitor that can pass through the blood-brain barrier. Pharmacological efficacy tests have shown that this product has a promoting effect on the passive avoidance operation acquisition of mice, and has a significant improvement on the memory consolidation disorder caused by scopolamine and sodium nitrite; it has a good promoting effect on the learning and memory reproduction of the light and dark discrimination operation of rats.
Registered Holders
-
JUBILANT PHARMOVA LTD
Active
United States
-
SCINOPHARM TAIWAN, LTD.
Active
Taiwan, China
-
Sanochemia Pharmazeutika AG
Active
Austria
Recommended Suppliers of Galantamine hydrobromide
-
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed AdditiveInquiryCAS No.: 1953-04-4Grade: Industrial GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of Apigenin,PQQ,NMNHInquiryUnit Price: $5.1-6.12 /G FOBCAS No.: 1953-04-4Grade: Chemical GradeContent: 99% -
CN
4 YRS
Business licensedTrader Supplier of intermediates ,fine chemical,food additives -
CN
4 YRS
Business licensedTrader Supplier of API OLED Organic intermediate -
CN
2 YRS
Business licensedTrader Supplier of Red Yeast Rice,Saw Palmetto Extract,Berberine HCLInquiryCAS No.: 1953-04-4Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Phenol, 2,5-diamino-4-methyl-, hydrobromide (1:2)
84282-47-3
-
Phenanthridinium, 3,8-diamino-5-methyl-6-phenyl-, bromide, hydrobromide (1:1:2)
94094-40-3
-
Hydrazine, hydrobromide (1:2)
23268-00-0
-
Quinoline, 4-bromo-8-fluoro-2-propyl-, hydrobromide (1:1) Formula
1204812-29-2
-
2-BROMO-1-(6-METHYL[1,3]THIAZOLO[3,2-B] [1,2,4]TRIAZOLO-5-YL)-1-ETHANONE HYDROBROMIDE Formula
187597-19-9
-
Piperazine, 1-butyl-, hydrobromide (1:2) Formula
84473-66-5
-
2-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]-1H-isoindole-1,3(2H)-dione hydrobromide (1:1) Structure
115338-32-4
-
Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), hydrobromide (1:1), (3aS,8aR)- Structure
6091-13-0
-
What is Benzamide, N-(aminocarbonyl)-4-[(2-methylhydrazinyl)methyl]-, hydrobromide (1:1)
366-71-2
-
What is α-[[(2-Bromoethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol hydrobromide (1:1)
129448-97-1